Literature DB >> 22478851

Regulators place spotlight on drug prices.

John Carroll.   

Abstract

Year:  2011        PMID: 22478851      PMCID: PMC3138386     

Source DB:  PubMed          Journal:  Biotechnol Healthc        ISSN: 1554-169X


× No keyword cloud information.
  2 in total

1.  Unintended consequences--the cost of preventing preterm births after FDA approval of a branded version of 17OHP.

Authors:  Joanne Armstrong
Journal:  N Engl J Med       Date:  2011-03-16       Impact factor: 91.245

2.  Prevention of recurrent preterm delivery by 17 alpha-hydroxyprogesterone caproate.

Authors:  Paul J Meis; Mark Klebanoff; Elizabeth Thom; Mitchell P Dombrowski; Baha Sibai; Atef H Moawad; Catherine Y Spong; John C Hauth; Menachem Miodovnik; Michael W Varner; Kenneth J Leveno; Steve N Caritis; Jay D Iams; Ronald J Wapner; Deborah Conway; Mary J O'Sullivan; Marshall Carpenter; Brian Mercer; Susan M Ramin; John M Thorp; Alan M Peaceman; Steven Gabbe
Journal:  N Engl J Med       Date:  2003-06-12       Impact factor: 91.245

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.